Lipid raft-regulated IGF-1R activation antagonizes TRAIL-induced apoptosis in gastric cancer cells

FEBS Letters

Volumn 587, Issue 23, 2013, Pages 3815-3823

  Xu, Ling ^a   Qu, Xiujuan ^a   Hu, Xuejun ^a   Zhu, Zhitu ^b   Li, Ce ^a   Li, Enze ^b   Ma, Yanju ^a   Song, Na ^a   Liu, Yunpeng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cbl b; IGF 1R; Lipid raft; TRAIL

Indexed keywords

CBL B PROTEIN; REGULATOR PROTEIN; SOMATOMEDIN C RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIPID RAFT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STOMACH CANCER;

CBL-B; IGF-1R; LIPID RAFT; TRAIL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; CELL LINE, TUMOR; HUMANS; IMIDAZOLES; MEMBRANE MICRODOMAINS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-CBL; PYRAZINES; RECEPTOR, IGF TYPE 1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84887997135     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.10.007     Document Type: Article

References (27)

1. J. Bornschein, and P. Malfertheiner Gastric carcinogenesis Langenbecks Arch. Surg. 396 2011 729 742
2. U. Schaefer, O. Voloshanenko, D. Willen, and H. Walczak TRAIL: a multifunctional cytokine Front. Biosci. 12 2007 3813 3824
3. L.S. Dickens, R.S. Boyd, R. Jukes-Jones, M.A. Hughes, G.L. Robinson, L. Fairall, J.W. Schwabe, K. Cain, and M. Macfarlane A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death Mol. Cell 47 2012 291 305
4. T. Trarbach, M. Moehler, V. Heinemann, C.H. Köhne, M. Przyborek, C. Schulz, V. Sneller, G. Gallant, and S. Kanzler Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer Br. J. Cancer 102 2010 506 512
5. F.A. Greco, P. Bonomi, J. Crawford, K. Kelly, Y. Oh, W. Halpern, L. Lo, G. Gallant, and J. Klein Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer Lung cancer 61 2008 82 90
6. L. Xu, X. Qu, Y. Luo, Y. Zhang, J. Liu, J. Qu, L. Zhang, and Y. Liu Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts Mol. Med. Rep. 4 2011 407 411
7. A. Belkhiri, S. Zhu, Z. Chen, M. Soutto, and W. El-Rifai Resistance to TRAIL is mediated by DARPP-32 in gastric cancer Clin. Cancer Res. 18 2012 3889 3900
8. S. Van Schaeybroeck, D.M. Kelly, J. Kyula, S. Stokesberry, D.A. Fennell, P.G. Johnston, and D.B. Longley Src and ADAM-17-mediated shedding of transforming growth factor-alpha is a mechanism of acute resistance to TRAIL Cancer Res. 68 2008 8312 8321
9. L. Xu, Y. Zhang, J. Liu, J. Qu, X. Hu, F. Zhang, H. Zheng, X. Qu, and Y. Liu TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells Eur. J. Cancer 48 2012 3288 3299
10. Y. Adachi, R. Li, H. Yamamoto, Y. Min, W. Piao, Y. Wang, A. Imsumran, H. Li, Y. Arimura, C.T. Lee, K. Imai, D.P. Carbone, and Y. Shinomura Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin Carcinogenesis 30 2009 1305 1313
11. T.B. Karasic, T.K. Hei, and V.N. Ivanov Disruption of IGF-1R signaling increases TRAIL-induced apoptosis: a new potential therapy for the treatment of melanoma Exp. Cell Res. 316 2010 1994 2007
12. M.O. Kinoshita, S. Furuya, S. Ito, Y. Shinoda, Y. Yamazaki, P. Greimel, Y. Ito, T. Hashikawa, T. Machida, Y. Nagatsuka, and Y. Hirabayashi Lipid rafts enriched in phosphatidylglucoside direct astroglial differentiation by regulating tyrosine kinase activity of epidermal growth factor receptors Biochem. J. 419 2009 565 575
13. R.J. Romanelli, K.R. Mahajan, C.G. Fulmer, and T.L. Wood Insulin-like growth factor-1-stimulated Akt phosphorylation and oligodendrocyte progenitor cell survival require cholesterol-enriched membranes J. Neurosci. Res. 87 2009 3369 3377
14. S. Hong, H. Huo, J. Xu, and K. Liao Insulin-like growth factor-1 receptor signaling in 3T3-L1 adipocyte differentiation requires lipid rafts but not caveolae Cell Death Differ. 11 2004 714 723
15. L. Xu, X. Qu, Y. Zhang, X. Hu, X. Yang, K. Hou, Y. Teng, J. Zhang, K. Sada, and Y. Liu Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts FEBS Lett. 583 2009 943 948
16. J. Liu, X. Qu, L. Xu, Y. Zhang, J. Qu, K. Hou, and Y. Liu Phosphoinositide 3-kinase/Akt and nuclear factor κB pathways are involved in tumor necrosis factor-related apoptosis-inducing ligand resistance in human gastric cancer cells Mol. Med. Rep. 3 2010 491 496
17. H. Huo, X. Guo, S. Hong, M. Jiang, X. Liu, and K. Liao Lipid rafts/caveolae are essential for insulin-like growth factor-1 receptor signaling during 3T3-L1 preadipocyte differentiation induction J. Biol. Chem. 278 2003 11561 11569
18. X. Qu, S.M. Miah, T. Hatani, M. Okazaki, N. Hori-Tamura, H. Yamamura, H. Hotta, and K. Sada Selective inhibition of Fcepsilon RI-mediated mast cell activation by a truncated variant of Cbl-b related to the rat model of type 1 diabetes mellitus J. Biochem. 137 2005 711 720
19. C. Stolfi, R. Caruso, E. Franzè, A. Rizzo, A. Rotondi, I. Monteleone, M.C. Fantini, F. Pallone, and G. Monteleone 2-Methoxy-5-amino-N- hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression Mol. Cancer Ther. 10 2011 1969 1981
20. H. Taniguchi, M. Horinaka, T. Yoshida, K. Yano, A.E. Goda, S. Yasuda, M. Wakada, and T. Sakai Targeting the glyoxalase pathway enhances TRAIL efficacy in cancer cells by downregulating the expression of antiapoptotic molecules Mol. Cancer Ther. 11 2012 2294 2300
21. S.S. Li, S. Yang, S. Wang, X.M. Yang, Q.L. Tang, and S.H. Wang Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway Oncol. Rep. 26 2011 1573 1579
22. Y.P. Hu, S.B. Patil, M. Panasiewicz, W. Li, J. Hauser, L.E. Humphrey, and M.G. Brattain Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor Cancer Res. 68 2008 8004 8013
23. J. Pavelić, T. Matijević, and J. Knezević Biological & physiological aspects of action of insulin-like growth factor peptide family Indian J. Med. Res. 125 2007 511 522
24. P. Zahradka, B. Storie, and B. Wright IGF-1 receptor transactivation mediates Src-dependent cortactin phosphorylation in response to angiotensin II Can. J. Physiol. Pharmacol. 87 2009 805 812
25. H.Y. Oh, E.J. Lee, S. Yoon, B.H. Chung, K.S. Cho, and S.J. Hong Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction Prostate 67 2007 1061 1069
26. M. Remacle-Bonnet, F. Garrouste, G. Baillat, F. Andre, J. Marvaldi, and G. Pommier Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily Am. J. Pathol. 167 2005 761 773
27. X. Qu, K. Sada, S. Kyo, K. Maeno, S.M. Miah, and H. Yamamura Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b Blood 103 2004 1779 1786